Defending the Strategy
The CEO makes the case for continued investment in a long-term growth strategy despite near-term pressure on margins. A director challenges the assumptions behind that decision.
Dialogue11

I want to be clear about the trade-off: we’re accepting some near-term margin pressure to build capabilities that should support more durable growth, not simply to chase revenue.
That’s a compelling framing, Grace, but it doesn’t establish that the investment will pay off. What evidence suggests these capabilities will generate returns rather than become a permanent cost base?
Fair challenge. We’re seeing stronger retention among customers using the expanded platform, and their average contract value is rising. Those are encouraging signals, though not yet proof of the full return.
How much of that improvement can you attribute to the investment itself? I’d be cautious about treating correlation as causation, particularly when customer mix has shifted.
We can’t isolate the effect with confidence yet. The comparison is directionally useful, but customer mix is a confounding factor. We’re building cohort-level analysis to give the board a cleaner read.
Meanwhile, the margin is under pressure. What would cause you to slow or stop the investment? A strategy that has no explicit off-ramp is difficult to govern.
We’ve set decision gates around adoption, retention, and unit economics. If adoption misses the agreed threshold for two consecutive quarters, or projected payback extends materially, we’ll reallocate rather than fund it by default.
What does “materially” mean in practice? The board needs a threshold we can evaluate, not a judgment call made after the results are in.
That’s fair. We should define the limit numerically with Finance before the next review. I’m not asking the board to underwrite an open-ended commitment; I’m asking for room to test the thesis against measurable milestones.
Then the case for continuing is conditional, not ideological. If the evidence weakens, you’ll change course—even if that means acknowledging the original thesis was too optimistic?
Absolutely. The strategy is a hypothesis, not a promise. I believe the long-term opportunity justifies disciplined investment, but we’ll bring forward the evidence, disclose the uncertainty, and adjust if the economics don’t validate it.
Vocabulary7
- near-term margin pressure
A short-term reduction in profitability. Here, it describes the financial cost of investing in the strategy now.
- permanent cost base
Ongoing expenses that become a lasting part of a company’s operations. The director worries the investment may add costs without generating enough returns.
- correlation as causation
The mistaken conclusion that because two things change together, one must have caused the other. Use this phrase when questioning whether evidence truly proves cause and effect.
- confounding factor
Something that affects the results and makes it harder to identify what caused a change. Here, shifts in customer mix may explain some of the improved performance.
- decision gates
Specific checkpoints or conditions used to decide whether a project should continue. They help make investment decisions measurable and accountable.
- off-ramp
A planned way to exit or change course. In this discussion, it means having clear conditions for slowing or stopping the investment.
- underwrite an open-ended commitment
To accept responsibility for supporting an investment with no clear limit or end point. The CEO clarifies that she is asking for a trial tied to measurable milestones instead.
Key Sentences7
- 1
What evidence suggests these capabilities will generate returns rather than become a permanent cost base?
This is a direct but professional way to ask for evidence that an investment will pay off. Reuse the structure “What evidence suggests [plan or action] will [desired result] rather than [risk]?”
- 2
I’d be cautious about treating correlation as causation, particularly when customer mix has shifted.
This sentence carefully challenges an interpretation of data without dismissing the evidence altogether. Use “I’d be cautious about…” to express measured skepticism in a professional discussion.
- 3
We can’t isolate the effect with confidence yet.
A concise way to acknowledge that the available data cannot yet prove what caused a result. You can reuse it when explaining limits in an analysis.
- 4
A strategy that has no explicit off-ramp is difficult to govern.
This makes the case for setting clear conditions for changing or ending a strategy. The structure “A [plan or arrangement] that has no explicit [safeguard] is difficult to [manage]” is useful in decision-making discussions.
- 5
I’m not asking the board to underwrite an open-ended commitment; I’m asking for room to test the thesis against measurable milestones.
This sentence distinguishes an unlimited commitment from a controlled, evidence-based trial. Reuse the contrast “I’m not asking for X; I’m asking for Y” to clarify a proposal.
- 6
The strategy is a hypothesis, not a promise.
This memorable contrast presents a strategy as something that must be tested rather than guaranteed. Use “X is a hypothesis, not a promise” to emphasize uncertainty and openness to evidence.
- 7
I believe the long-term opportunity justifies disciplined investment, but we’ll bring forward the evidence, disclose the uncertainty, and adjust if the economics don’t validate it.
This sentence balances confidence in a plan with accountability and willingness to change course. Its structure is useful for presenting a position while acknowledging risks and commitments.